|
1
|
Duley L: The global impact of
pre-eclampsia and eclampsia. Semin Perinatol. 33:130–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
ACOG Committee on Practice
Bulletin-Obstetrics: ACOG practice bulletin. Diagnosis and
management of preeclampsia and eclampsia Number 33, January 2002.
Obstet Gynecol. 99:159–167. 2002.
|
|
3
|
Duckitt K and Harrington D: Risk factors
for pre-eclampsia at antenatal booking: Systematic review of
controlled studies. BMJ. 330:565–570. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Redman CW and Sargent IL: Latest advances
in understanding preeclampsia. Science. 308:1592–1594. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Steegers EA, von Dadelszen P, Duvekot JJ
and Pijnenborg R: Pre-eclampsia. Lancet. 376:631–644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan YC, Banerjee J, Choi SY and Sen CK:
miR-210: The master hypoxamir. Microcirculation. 19:215–223. 2012.
View Article : Google Scholar :
|
|
7
|
Khalil RA and Granger JP: Vascular
mechanisms of increased arterial pressure in preeclampsia: Lessons
from animal models. Am J Physiol Regul Integr Comp Physiol.
283:R29–R45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Devor EC, Santillan DA and Santillan MK:
Preeclampsia and MicroRNAs. Proceed Obstet Gynecol. 3:1–10.
2013.
|
|
12
|
Pillar N, Yoffe L, Hod M and Shorman N:
The possible involvement of microRNAs in preeclampsia and
gestational diabetes mellitus. Best Pract Res Clin Obstet Gynaecol.
29:176–182. 2015. View Article : Google Scholar
|
|
13
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A Pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ventura W, Koide K, Hori K, Yotsumoto J,
Sekizawa A, Saito H and Okai T: Placental expression of microRNA-17
and -19b is down-regulated in early pregnancy loss. Eur J Obstet
Gynecol Reprod Biol. 169:28–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Pogosova-Agadjanyan EL, Peterson
A, Noteboom J, O'Briant KC, et al: Circulating microRNAs as stable
blood-based markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gantier MP, McCoy CE, Rusinova I, Saulep
D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F and
Williams BR: Analysis of microRNA turnover in mammalian cells
following Dicer1 ablation. Nucleic Acids Res. 39:5692–5703. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arroyo JD, Chevillet JR, Kroh EM, Ruf IK,
Pritchard CC, Gibson DF, Mitchell PS, Bennett CF,
Pogosova-Agadjanyan EL, Stirewalt DL, et al: Argonaute2 complexes
carry a population of circulating microRNAs independent of vesicles
in human plasma. Proc Natl Acad Sci USA. 108:5003–5008. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot
CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, et al: Integrated
analyses identify a master microRNA regulatory network for the
mesenchymal subtype in serous ovarian cancer. Cancer Cell.
23:186–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Devor EJ, Mik JN, Ramachandran S,
Goodheart MJ and Leslie KK: Global dysregulation of the chromosome
14q32 imprinted region in uterine carcinosarcoma. Exp Ther Med.
3:677–682. 2012.PubMed/NCBI
|
|
21
|
Wang W, Feng L, Zhang H, Hachy S, Satohisa
S, Laurent LC, Parast M, Zheng J and Chen DB: Preeclampsia
up-regulates angiogenesis-associated microRNA (ie, miR-17,-20a and
20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin
Endocrinol Metab. 97:1051–1059. 2012. View Article : Google Scholar
|
|
22
|
Morales-Prieto DM, Ospina-Prieto S,
Chaiwangyen W, Schoenleben M and Markert UR: Pregnancy-associated
miRNA-clusters. J Reprod Immunol. 97:51–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Glazov EA, McWilliam S, Barris WC and
Dalrymple BP: Origin, evolution and biological role of miRNA
cluster in DLK-DIO3 genomic region in placental mammals. Mol Biol
Evol. 25:939–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noguer-Dance M, Abu-Amero S, Al-Khtib M,
Lefèvre A, Coullin P, Moore GE and Cavaillé J: The primate-specific
microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol
Genet. 19:3566–3582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kotlabova K, Doucha J and Hromadnikova I:
Placental-specific microRNA in maternal circulation-identification
of appropriate pregnancy-associated microRNAs with diagnostic
potential. J Reprod Immunol. 89:185–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pineles BL, Romero R, Montenegro D, Tarca
AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P,
et al: Distinct subsets of microRNAs are expressed differentially
in the human placentas of patients with preeclampsia. Am J Obstet
Gynecol. 196:261–266. 2007.PubMed/NCBI
|
|
28
|
Enquobahrie DA, Abetew DF, Sorensen TK,
Willoughby D, Chidambaram K and Williams MA: Placental microRNA
expression in pregnancies complicated by preeclampsia. Am J Obstet
Gynecol. 204:12–21. 2011.
|
|
29
|
Mayor-Lynn K, Toloubeydokhti T, Cruz AC
and Chegini N: Expression profile of microRNAs and mRNAs in human
placentas from pregnancies complicated by preeclampsia and preterm
labor. Reprod Sci. 18:46–56. 2011. View Article : Google Scholar
|
|
30
|
Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z
and Wang H: Circulating microRNAs are elevated in plasma from
severe preeclamptic pregnancies. Reproduction. 143:389–397. 2012.
View Article : Google Scholar
|
|
31
|
Xu P, Zhao Y, Liu M, Wang Y, Wang H, Li
YX, Zhu X, Yao Y, Wang H, Qiao J, et al: Variations of microRNAs in
human placentas and plasma from preeclamptic pregnancy.
Hypertension. 63:1276–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Diao Z, Su L, Sun H, Li R, Cui H
and Hu Y: MicroRNA-155 contributes to preeclampsia by
down-regulating CYR61. Am J Obstet Gynecol. 202:466–472.
2010.PubMed/NCBI
|
|
33
|
Li H, Ge Q, Guo L and Lu Z: Maternal
Plasma miRNAs expression in Preeclamptic Pregnancies. Biomed Res
Int. 2013:9702652013.PubMed/NCBI
|
|
34
|
Luque A, Farwati A, Crovetto F, Crispi F,
Figueras F, Gratacos E and Aran JM: Usefulness of circulating
microRNAs for the prediction of early preeclampsia at
first-trimester of pregnancy. Sci Rep. 4:48822014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ura B, Feriotto G, Monasta L, Bilel S,
Zweyer M and Celeghini C: Potential role of circulating microRNAs
as early markers of preeclampsia. Taiwan J Obstet Gynecol.
53:232–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu Y, Li P, Hao S, Liu L, Zhao J and Hou
Y: Differential expression of microRNAs in the placentae of Chinese
patients with severe pre-eclampsia. Clin Chem Lab Med. 47:923–929.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu XM, Han T, Sargent IL, Yin GW and Yao
YQ: Differential expression profile of microRNAs in human placentas
from preeclamptic pregnancies vs normal pregnancies. Am J Obstet
Gynecol. 200:661–667. 2009.PubMed/NCBI
|
|
38
|
Yang WJ, Yang DD, Na S, Sandusky GE, Zhang
Q and Zhao G: Dicer is required for embryonic angiogenesis during
mouse development. J Biol Chem. 280:9330–9335. 2005. View Article : Google Scholar
|
|
39
|
Su X, Chakravarti D, Cho MS, Liu L, Gi YJ,
Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, et al:
Tap63 suppresses metastasis through coordinate regulation of Dicer
and miRNAs. Nature. 467:986–990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vitoratos N, Hassiakos D and Lavazzo C:
Molecular mechanisms of preeclampsia. J Pregnancy.
2012:2983432012.PubMed/NCBI
|
|
41
|
Muniyappa MK, Dowling P, Henry M, Meleady
P, Doolan P, Gammell P, Clynes M and Barron N: MiRNA-29a regulates
the expression of numerous proteins and reduces the invasiveness
and proliferation of human carcinoma cell lines. Eur J Cancer.
45:3104–3118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shioya M, Obayashi S, Tabunoki H, Arima K,
Saito Y, Ishida T and Satoh J: Aberrant microRNA expression in the
brains of neurodegenerative diseases: MiR-29a decreased in
Alzheimer disease brains targets neurone navigator 3. Neuropathol
Appl Neurobiol. 36:320–330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang Q, Lu J, Wang S, Li H, Ge Q and Lu Z:
Application of next-generation sequencing technology to profile the
circulating microRNAs in the serum of preeclampsia versus normal
pregnant women. Clin Chim Acta. 412:2167–2173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xie T, Liang J, Liu N, Wang Q, Li Y, Noble
PW and Jiang D: MicroRNA-127 inhibits lung inflammation by
targeting IgG Fcγ receptor I. J Immunol. 188:2437–2444. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wulfken LM, Moritz R, Ohlmann C,
Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel
G, von Ruecker A, Müller SC and Ellinger J: MicroRNAs in renal cell
carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS
One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zeng ZL, Li FJ, Gao F, Sun DS and Yao L:
Upregulation of miR-650 is correlated with down-regulation of ING4
and progression of hepatocellular carcinoma. J Surg Oncol.
107:105–110. 2013. View Article : Google Scholar
|
|
47
|
Chim SS, Shing TK, Hung EC, Leung TY, Lau
TK, Chiu RW and Lo YM: Detection and characterization of placental
microRNAs in maternal plasma. Clin Chem. 54:482–490. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mincheva-Nilsson L and Baranov V: The role
of placental exosomes in reproduction. Am J Reprod Immunol.
63:520–533. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li
L, Xin H and Sun S: Elevated levels of hypoxia-inducible
microRNA-210 in pre-eclampsia: New insights into molecular
mechanisms for the disease. J Cell Mol Med. 16:249–259. 2012.
View Article : Google Scholar
|
|
50
|
Luo R, Shao X, Xu P, Liu Y, Wang Y, Zhao
Y, Liu M, Ji L, Li YX, Chang C, et al: MicroRNA-210 contributes to
preeclampsia by downregulating potassium channel modulatory factor
1. Hypertension. 64:839–845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ishibashi O, Ohkuchi A, Ali MM, Kurashina
R, Luo S, Ishikawa T, Takizawa T, Hirashima C, Takahashi K, Migita
M, et al: Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by
miR-210 and miR-518c that are aberrantly expressed in preeclamptic
placentas: A novel marker for predicting preeclampsia.
Hypertension. 59:265–273. 2012. View Article : Google Scholar
|
|
52
|
Duley L, Henderson-Smart DJ, Meher S and
King JF: Antiplatelet agents for preventing pre-eclampsia and its
complications. Cochrane Database Syst Rev. CD0046592007.PubMed/NCBI
|
